Table 1.

Summary of the biological effects of the peptide fragments contained within the 1^st type III repeat of plasma fibronectin, (FNIII₁).

Peptide	Peptide sequence	Survival activitya	FN/PDGF-BB binding inhibitionb	Control c Dose (%) Max dilation		Stress c Dose (%) Max dilation
EVA-1	PSHISKYILRWRPK	Yes	95.5%	10−9M	22%	10−13M	32%
P18	YILRWRPK	No	26%	10−8M	26%	–	–
P7	ILRWRPK	No	0.1%	10−8M	28%	10−12M	29%
P39	LRWRPK	No	0.0%	10−11M	8%	–	–
P37	RWRPK	No	0.0%	10−11M	19%	10−15M	45%

^a(ref #17, Lin, et al., 2011);

^b(Ref #18, Lin, et al., 2014; Ref #35, Zhu, et al., 2014);

^cpresent study, terminal arterioles.